dc.contributor.author
Wedemeyer, Friederike
dc.contributor.author
Kaminski, Jakob A.
dc.contributor.author
Zillich, Lea
dc.contributor.author
Hall, Alisha S. M.
dc.contributor.author
Friedel, Eva
dc.contributor.author
Witt, Stephanie H.
dc.date.accessioned
2022-08-04T09:57:56Z
dc.date.available
2022-08-04T09:57:56Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/35719
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-35434
dc.description.abstract
Purpose of Review: In this study, we illustrate recent findings regarding the genetics and epigenetics of alcohol use disorder (AUD). We further outline the future direction of genetic and epigenetic research in AUD.
Recent Findings: Recent genome- and epigenome-wide studies allow new insight into genetic and epigenetic variation associated with AUD. The largest EWAS of AUD so far/to date found evidence for altered glucocorticoid receptor regulation. Longitudinal studies provide insight into the dynamics of the disease. Analyses of postmortem brain tissue reveal the impact of chronic alcohol consumption on DNA methylation in the brain.
Summary: Genetic and environmental factors-mediated via epigenetic mechanisms-play an important role in AUD. Although knowledge of the biological underpinnings of AUD is still limited, ongoing research will ultimately lead to the development of biomarkers for disease classification, course of disease, and treatment response to support personalized medicine in the future.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Alcohol use disorder
en
dc.subject
Neurobiology
en
dc.subject
Personalized medicine
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Prospects of Genetics and Epigenetics of Alcohol Use Disorder
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s40429-020-00331-x
dcterms.bibliographicCitation.journaltitle
Current Addiction Reports
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
446
dcterms.bibliographicCitation.pageend
452
dcterms.bibliographicCitation.volume
7
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
2196-2952